Related Experiment Video
Updated: Nov 6, 2025

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Structural impacts of two disease-linked ADAR1 mutants: a molecular dynamics study.
Wen-Chieh Huang1, Chia-Hung Hsu2, Titus V Albu3
1Institute of Precision Medicine, National Sun Yat-sen University, No. 70 Lien-Hai Road, Kaohsiung, 80424, Taiwan.
Structural modeling reveals how mutations in the Adenosine deaminases acting on RNA 1 (ADAR1) enzyme disrupt RNA editing by affecting enzyme-substrate binding, offering insights into autoinflammatory diseases.
Area of Science:
- Molecular Biology
- Structural Biology
- Genetics
Background:
- Adenosine deaminases acting on RNA (ADARs) are crucial RNA-editing enzymes.
- ADAR1 editing dysregulation is implicated in autoinflammatory diseases due to genetic mutations.
- The structure of the ADAR1 deaminase domain is not experimentally determined, hindering mechanistic understanding.
Purpose of the Study:
- To computationally model the ADAR1 deaminase domain in wild-type and mutant forms.
- To investigate the structural basis of reduced deaminase activity in pathogenic variants.
- To elucidate the role of structural complementarity in ADAR1-dsRNA recognition.
Main Methods:
- Homology modeling
- AlphaFold2 for structural model construction
- Analysis of wild-type and two pathogenic ADAR1 variants (R892H, Y1112F)
Main Results:
- Structural models of ADAR1 deaminase domain (wild-type, R892H, Y1112F) were generated.
- Key residues (E1008, K1120) are critical for binding dsRNA by interacting with its minor and major grooves.
- Mutations R892H and Y1112F disrupt the position of K1120, impairing substrate RNA binding.
Conclusions:
- Structural complementarity between ADAR1 and dsRNA is vital for enzyme-substrate recognition.
- Specific mutations hinder ADAR1 activity by altering key structural interactions necessary for RNA binding.
- Understanding these structural impacts provides insights into ADAR1-related autoinflammatory diseases.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016